Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

Logo
IBRX US​

ImmunityBio, Inc.(IBRX US)

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Financials

Income StatementBalance Sheet

Cash Flow

Millions USD (ex. Per Share)
FY201312/31/2013
FY201412/31/2014
FY201512/31/2015
FY201612/31/2016
FY201712/31/2017
FY201812/31/2018
FY201912/31/2019
FY202012/31/2020
FY202112/31/2021
FY202212/31/2022
FY202312/31/2023
FY202412/31/2024
FY202512/31/2025
Last 12M03/31/2026
Net Income-583.9-413.6-351.5-854.5
Depreciation & Amortization18.517.615.516.1
Stock Based Compensation49.234.436.835.4
Change in Working Capital4.0-19.4-54.3-32.8
Other Non-Cash Items145.4-10.248.5492.6
Net Cash from Operating Activities-366.8-391.2-304.9-294.4
-Investments in Property, Plant & Equipment-30.6-6.9-4.3-4.9
-Acquisitions Net--1.0--
-Purchases of Investments-10.4-140.2-241.4-209.8
Sales/Maturities of Investments10.5136.695.8209.7
Other Investing Activities--0.7--181.4
Net Cash from Investing Activities-30.5-12.2-149.8-185.6
Net Debt Issuance258.696.91.71.8
Net Stock Issuance110.1111.4400.8632.2
-Net Dividends Paid----
Other Financing Activities189.673.4-2.3164.7
Net Cash from Financing Activities558.3281.6400.2625.1
Effect of Forex Changes-0.3-0.00.0-0.0
Net Change in Cash160.8-121.9-54.5145.1
Cash at End of Period265.8143.989.4493.6
Operating Cash Flow-366.8-391.2-304.9-294.4
-Capital Expenditure-30.6-6.9-3.8-4.5
Free Cash Flow-397.3-398.1-308.8-298.9